 Sydney, Aug. 27, 2021 GLOBE NEWSWIRE -- SYDNEY, AUSTRALIA 27 August 2021 Immutep Limited ASX: IMM; NASDAQ: IMMP Immutep or the Company, is pleased to announce the grant of patent no. ZL201580013695.X entitled Antibody molecules to LAG-3 and uses thereof by the Chinese Patent Office. 